BI Asset Management Fondsmaeglerselskab’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.7M Sell
3,229
-23,536
-88% -$13.2M 0.01% 448
2026
Q1
$15M Sell
26,765
-3,381
-11% -$2.17M 0.16% 121
2025
Q4
$20.4M Sell
30,146
-14,883
-33% -$10.1M 0.18% 109
2025
Q3
$28.8M Buy
45,029
+17,848
+66% +$10.8M 0.26% 81
2025
Q2
$14.6M Buy
27,181
+20,052
+281% +$9.59M 0.14% 138
2025
Q1
$2.99M Sell
7,129
-9,379
-57% -$4.07M 0.03% 291
2024
Q4
$6.83M Sell
16,508
-9,483
-36% -$4.16M 0.07% 187
2024
Q3
$13.1M Buy
25,991
+545
+2% +$265K 0.23% 87
2024
Q2
$12.4M Sell
25,446
-5,617
-18% -$2.82M 0.2% 101
2024
Q1
$16.8M Sell
31,063
-14,544
-32% -$7.95M 0.32% 80
2023
Q4
$25.3M Buy
45,607
+16,249
+55% +$7.63M 0.54% 48
2023
Q3
$12.8M Buy
29,358
+20,306
+224% +$10.1M 0.3% 87
2023
Q2
$4.55M Buy
9,052
+772
+9% +$370K 0.11% 151
2023
Q1
$4.14M Buy
8,280
+6,702
+425% +$3.21M 0.11% 149
2022
Q4
$644K Buy
1,578
+1,227
+350% +$476K 0.02% 388
2022
Q3
$114K Sell
351
-1,346
-79% -$494K 0.01% 407
2022
Q2
$595K Buy
+1,697
New +$692K 0.03% 289
2020
Q4
– Sell
-10,974
Closed -$4.31M – 429
2020
Q3
$4.31M Sell
10,974
-4,502
-29% -$1.66M 0.2% 109
2020
Q2
$5.11M Sell
15,476
-1,703
-10% -$493K 0.26% 88
2020
Q1
$4.16M Buy
+17,179
New +$4.48M 0.25% 81

Other funds holding IDXX

BI Asset Management Fondsmaeglerselskab's IDXX Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab reduced its Idexx Laboratories (IDXX) stake by 88% in Q2 2026, selling an estimated $13.2M and leaving 3,229 shares worth $1.7M. The position accounts for 0.01% of the portfolio, ranked #448.

BI Asset Management Fondsmaeglerselskab first reported a position in IDXX in Q1 2020 and has held it in 20 quarters since. The position peaked at $28.8M in Q3 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 3,229 shares of Idexx Laboratories worth $1.7M as of Q2 2026.
  • BI Asset Management Fondsmaeglerselskab sold 23,536 Idexx Laboratories shares in Q2 2026, an estimated $13.2M.
  • Idexx Laboratories made up 0.01% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #448 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Idexx Laboratories in Q1 2020 and has held it in 20 quarters since.
  • BI Asset Management Fondsmaeglerselskab's Idexx Laboratories position peaked at $28.8M in Q3 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.